S. Korean rehabilitation device wins FDA approval for medical device - Aju Business Daily

SEOUL -- A South Korean-made rehabilitation instrumentality designed to assistance degenerative genu arthritis patients negociate and amended their little assemblage musculus spot was approved by the United States Food and Drug Administration (FDA) arsenic a aesculapian device. The FDA support volition assistance the device's shaper accelerate overseas sales.
 
Degenerative arthritis successful genu joints sometimes causes musculus atrophy successful patients owed to symptom that hinders patients from walking and stimulate the little muscles successful their legs and hip. South Korea with a colonisation of immoderate 51 cardinal has go a rapidly aging state with astir 20 percent of radical expected to scope the property of 65 years aged and older by 2025. About 38 percent of elderlies endure from degenerative genu arthritis.
 
The Ulsan National Institute of Science and Technology (UNIST) said that rehabilitation instrumentality shaper Cotras received FDA support for "MOBILISE," an workout instrumentality for patients with degenerative genu arthritis. The instrumentality was commercialized utilizing technologies jointly developed by UNIST, the Korea Institute of Science and Technology (KIST), and Seoul National University Bundang Hospital.
 
The probe institutes and the assemblage infirmary person been processing related technologies done a government-led task since September 2020. The exertion was transferred to Cotras for the aboriginal commercialization of MOBILISE.
 
The rehabilitation instrumentality tin connection step-by-step programs for elderlies by analyzing the level of musculus atrophy. UNIST said the instrumentality is casual to usage astatine location acknowledgment to its latest user-friendly features specified arsenic augmented world (AR) and virtual world (VR) interfaces that promote patients to prosecute successful their rehabilitation programme much often.